Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACADIA HEALTHCARE COMPANY, INC.

(ACHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inpatient Admissions, Outpatient Visits Log Annual Growth For Third Straight Month, Prompting BofA to Raise Price Targets For Healthcare Facilities Providers

06/15/2021 | 04:10pm EDT


ę MT Newswires 2021
All news about ACADIA HEALTHCARE COMPANY, INC.
08/04ACADIA HEALTHCARE : Deutsche Bank Raises Acadia Healthcare's PT to $70 from $62,..
MT
08/04ACADIA HEALTHCARE : Credit Suisse Raises Acadia Healthcare's PT to $68 from $60 ..
MT
08/04ACADIA HEALTHCARE : RBC Raises Price Target on Acadia Healthcare to $76 From $74..
MT
08/04ACADIA HEALTHCARE : Citigroup Adjusts Acadia Healthcare's Price Target to $77 Fr..
MT
08/03ACADIA HEALTHCARE : Management's Discussion and Analysis of Financial Condition ..
AQ
08/02ACADIA HEALTHCARE : Q2 Earnings Snapshot
AQ
08/02ACADIA HEALTHCARE : Q2 Profit Nudges Higher as Revenue Grows
MT
08/02ACADIA HEALTHCARE : Earnings Flash (ACHC) ACADIA HEALTHCARE COMPANY Posts Q2 EPS..
MT
08/02ACADIA HEALTHCARE : Earnings Flash (ACHC) ACADIA HEALTHCARE COMPANY Posts Q2 Rev..
MT
08/02ACADIA HEALTHCARE COMPANY, INC. : Results of Operations and Financial Condition,..
AQ
More news
Financials (USD)
Sales 2021 2 303 M - -
Net income 2021 195 M - -
Net Debt 2021 1 300 M - -
P/E ratio 2021 29,1x
Yield 2021 -
Capitalization 5 616 M 5 616 M -
EV / Sales 2021 3,00x
EV / Sales 2022 2,79x
Nbr of Employees 20 000
Free-Float 98,5%
Chart ACADIA HEALTHCARE COMPANY, INC.
Duration : Period :
Acadia Healthcare Company, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACADIA HEALTHCARE COMPANY, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 62,50 $
Average target price 73,50 $
Spread / Average Target 17,6%
EPS Revisions
Managers and Directors
Debra Kay Osteen Chief Executive Officer & Director
David M. Duckworth Chief Financial Officer
Reeve Byron Waud Chairman
Michael V. Genovese Chief Medical Officer
John S. Hollinsworth Executive Vice President-Operations